Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimization of biomass and target protein yield for Phase III clinical trial to evaluate Angiotensin Converting Enzyme 2 expressed in lettuce chloroplasts to reduce SARS-CoV-2 infection and transmission.
Ganesan PK, Kulchar RJ, Kaznica P, Montoya-Lopez R, Green BJ, Streatfield SJ, Daniell H. Ganesan PK, et al. Among authors: green bj. Plant Biotechnol J. 2023 Feb;21(2):244-246. doi: 10.1111/pbi.13954. Epub 2022 Dec 1. Plant Biotechnol J. 2023. PMID: 36314106 Free PMC article. Clinical Trial. No abstract available.
Debulking SARS-CoV-2 in saliva using angiotensin converting enzyme 2 in chewing gum to decrease oral virus transmission and infection.
Daniell H, Nair SK, Esmaeili N, Wakade G, Shahid N, Ganesan PK, Islam MR, Shepley-McTaggart A, Feng S, Gary EN, Ali AR, Nuth M, Cruz SN, Graham-Wooten J, Streatfield SJ, Montoya-Lopez R, Kaznica P, Mawson M, Green BJ, Ricciardi R, Milone M, Harty RN, Wang P, Weiner DB, Margulies KB, Collman RG. Daniell H, et al. Among authors: green bj. Mol Ther. 2022 May 4;30(5):1966-1978. doi: 10.1016/j.ymthe.2021.11.008. Epub 2021 Nov 11. Mol Ther. 2022. PMID: 34774754 Free PMC article.
Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: a phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in healthy adults.
Chichester JA, Jones RM, Green BJ, Stow M, Miao F, Moonsammy G, Streatfield SJ, Yusibov V. Chichester JA, et al. Among authors: green bj. Viruses. 2012 Nov 19;4(11):3227-44. doi: 10.3390/v4113227. Viruses. 2012. PMID: 23202523 Free PMC article. Clinical Trial.
Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana.
Shoji Y, Prokhnevsky A, Leffet B, Vetter N, Tottey S, Satinover S, Musiychuk K, Shamloul M, Norikane J, Jones RM, Chichester JA, Green BJ, Streatfield SJ, Yusibov V. Shoji Y, et al. Among authors: green bj. Hum Vaccin Immunother. 2015;11(1):118-23. doi: 10.4161/hv.34365. Epub 2014 Nov 1. Hum Vaccin Immunother. 2015. PMID: 25483524 Free PMC article.
Safety and immunogenicity of a plant-derived recombinant protective antigen (rPA)-based vaccine against Bacillus anthracis: A Phase 1 dose-escalation study in healthy adults.
Paolino KM, Regules JA, Moon JE, Ruck RC, Bennett JW, Remich SA, Mills KT, Lin L, Washington CN, Fornillos GA, Lindsey CY, O'Brien KA, Shi M, Mark Jones R, Green BJ, Tottey S, Chichester JA, Streatfield SJ, Yusibov V. Paolino KM, et al. Among authors: green bj. Vaccine. 2022 Mar 15;40(12):1864-1871. doi: 10.1016/j.vaccine.2022.01.047. Epub 2022 Feb 10. Vaccine. 2022. PMID: 35153091 Clinical Trial.
A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge.
Shoji Y, Jones RM, Mett V, Chichester JA, Musiychuk K, Sun X, Tumpey TM, Green BJ, Shamloul M, Norikane J, Bi H, Hartman CE, Bottone C, Stewart M, Streatfield SJ, Yusibov V. Shoji Y, et al. Among authors: green bj. Hum Vaccin Immunother. 2013 Mar;9(3):553-60. doi: 10.4161/hv.23234. Epub 2013 Jan 7. Hum Vaccin Immunother. 2013. PMID: 23296194 Free PMC article.
Plant-Produced Subunit Vaccine Candidates against Yellow Fever Induce Virus Neutralizing Antibodies and Confer Protection against Viral Challenge in Animal Models.
Tottey S, Shoji Y, Jones RM, Chichester JA, Green BJ, Musiychuk K, Si H, Manceva SD, Rhee A, Shamloul M, Norikane J, Guimarães RC, Caride E, Silva ANMR, Simões M, Neves PCC, Marchevsky R, Freire MS, Streatfield SJ, Yusibov V. Tottey S, et al. Among authors: green bj. Am J Trop Med Hyg. 2018 Feb;98(2):420-431. doi: 10.4269/ajtmh.16-0293. Epub 2017 Nov 30. Am J Trop Med Hyg. 2018. PMID: 29231157 Free PMC article.
Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults.
Chichester JA, Green BJ, Jones RM, Shoji Y, Miura K, Long CA, Lee CK, Ockenhouse CF, Morin MJ, Streatfield SJ, Yusibov V. Chichester JA, et al. Among authors: green bj. Vaccine. 2018 Sep 18;36(39):5865-5871. doi: 10.1016/j.vaccine.2018.08.033. Epub 2018 Aug 17. Vaccine. 2018. PMID: 30126674 Free PMC article. Clinical Trial.
Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adults.
Cummings JF, Guerrero ML, Moon JE, Waterman P, Nielsen RK, Jefferson S, Gross FL, Hancock K, Katz JM, Yusibov V; Fraunhofer USA Center for Molecular Biotechnology Study Group. Cummings JF, et al. Vaccine. 2014 Apr 17;32(19):2251-9. doi: 10.1016/j.vaccine.2013.10.017. Epub 2013 Oct 12. Vaccine. 2014. PMID: 24126211 Free PMC article. Clinical Trial.
177 results